30/04/2025
*PRACTICE CHANGING UPDATE*
*Revised diagnostic criteria for Allergic Bronchopulmonary Aspergillosis (ABPA) 2024
• There is no individual test to establish the diagnosis of allergic bronchopulmonary aspergillosis, and the diagnosis is usually confirmed by a combination of clinical, radiographic, and immunologic findings. We favor using the 2024 revised diagnostic criteria proposed by the International Society for Human and Animal Mycology (ISHAM) that simplify prior diagnostic scheme.
• Allergic Bronchopulmonary Aspergillosis (ABPA), a complex hypersensitivity reaction to airway colonization with _Aspergillus fumigatus_ can be hard to distinguish from difficult-to-treat asthma or cystic fibrosis. The International Society for Human and Animal Mycology (ISHAM) working group for ABPA recently published in May 2024 , a revised diagnostic criteria as shown in table below that make some key changes to improve the sensitivity and specificity of the diagnosis:
•Total serum immunoglobulin (Ig) E levels of ≥500 international units/mL are sufficient for the diagnosis, rather than the previously higher threshold of 1000 international units/mL.
•Elevated Aspergillus IgG levels by enzyme immunoassay or lateral flow assay are more sensitive for detecting sensitivity to Aspergillus antigens and should be used preferentially over Aspergillus serum precipitins.
*TABLE*
📋 ABPA Diagnostic Criteria (ISHAM)
🔹 Predisposing Conditions (≥1):
- Asthma
- Cystic fibrosis
🔹 Obligatory Criteria (both required):
- Serum IgE to Aspergillus ≥ 0.35 kU/L
or skin test positive
- Total IgE ≥ 500 IU/mL
🔹 Other Criteria (≥2 of the following):
- Elevated Aspergillus IgG
- Pulmonary opacities (HRCT or X-ray)
- Eosinophil count > 500 cells/μL
📝 Notes:
- IgE < 500 IU/mL allowed if all other criteria met
- IgG preferred over precipitins
- HRCT: Bronchiectasis
*Reference*
1. Agarwal R, Sehgal IS, Muthu V, et al. _Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary
aspergillosis/mycoses. Eur Respir J 2024; 63(4):2400061.
==
Summary contributed by
*Dr. Ashutosh Bhardwaj*
HOD Critical Care
Dharamshila Narayana Superspeciality Hospital, Delhi.
*Dr. Prashant Kumar*
Editor Critical Care WAarticles